Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer.
The expression of the mucin-bound sialyl-Lewisx epitope is increased in the tissue of most colorectal carcinomas and in the sera of about 30% of tumor patients. In colon cancer, a portion of the sialyl-Lex groups detectable with the monoclonal antibody AM-3 is located on MUC1 (C. Hanski et al., Cancer Res., 53: 4082-4088, 1993). In order to characterize the major colon carcinoma-associated sialyl-Lex-positive glycoprotein components, the tissue- and serum-derived antigens were investigated. The buoyant densities of the sialyl-Lewisx-positive antigens from tumor and normal colonic tissues and from sera of patients with colon carcinoma and healthy donors correspond to that of mucins (1.40 g/ml). The sialyl-Lex-positive mucins purified from both tissues elute under nonreducing conditions in the void volume of a Sepharose CL-2B column, indicating a molecular mass more than 2 x 10(7) daltons. They yield in immunoblot after SDS gel electrophoresis under reducing conditions a main band at an apparent M(r) 880,000. Radioactive labeling revealed that the band at M(r) 880,000 is the major protein component in sialyl-Lewisx-positive mucins both from tumor and normal colonic tissue. In sera of colon carcinoma patients, the sialyl-Lex moiety is also detectable mainly on a M(r) 880,000 glycoprotein band and, additionally, on a M(r) 140,000 molecule as well as on alpha 1-acid glycoprotein. Sera from healthy donors exhibited only a sialyl-Lex-positive glycoprotein with the apparent M(r) 140,000. Sandwich ELISA as well as immunoblots of mucins purified from the colon carcinoma cell line LS174T indicated that the sialyl-Lex moiety migrating in the M(r) 880,000 band is located on MUC2 protein core. Together, these data suggest that sialyl-Lex antigen in colon, colon carcinoma, and the sera of patients with this tumor is located on the MUC2 molecule, consisting of several subunits with an apparent M(r) 880,000, linked via disulfide bridges. The increase of sialyl-Lex expression in colon carcinomas appears to be mainly due to a more frequent transfer of sialyl-Lex moieties onto the mucin core in tumor tissue.
Hanski
C
C
Klinikum Benjamin Franklin der Freien Universität Berlin, Department of Gastroenterology, Germany.
Hanski
M L
ML
Zimmer
T
T
Ogorek
D
D
Devine
P
P
Riecken
E O
EO
D000911:Antibodies, Monoclonal; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis* / Q000097:blood* / Q000276:immunology; D002845:Chromatography; D003106:Colon / Q000737:chemistry* / Q000276:immunology; D003110:Colonic Neoplasms / Q000097:blood* / Q000737:chemistry*; D015179:Colorectal Neoplasms / Q000097:blood* / Q000737:chemistry*; D004586:Electrophoresis; D006801:Humans; D015151:Immunoblotting; D008970:Molecular Weight; D009077:Mucins / Q000032:analysis* / Q000097:blood* / Q000276:immunology; D009844:Oligosaccharides / Q000032:analysis* / Q000097:blood* / Q000276:immunology; D000080506:Sialyl Lewis X Antigen; D012967:Sodium Dodecyl Sulfate
D000911:Antibodies, Monoclonal; D015295:Antigens, Tumor-Associated, Carbohydrate; D009077:Mucins; D009844:Oligosaccharides; D000080506:Sialyl Lewis X Antigen; D012967:Sodium Dodecyl Sulfate